Detalles de la búsqueda
1.
Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer.
Br J Cancer
; 2024 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38519705
2.
Uterine angioleiomyoma with disseminated intravascular coagulation: a case report.
BMC Womens Health
; 23(1): 157, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37013521
3.
Impact of Smad4 and p53 mutations on the prognosis of patients with pancreatic ductal adenocarcinoma undergoing chemotherapy.
Int J Clin Oncol
; 28(11): 1511-1519, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37596505
4.
Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma.
Cancer Sci
; 113(2): 660-673, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34837284
5.
Predictive value of EGFR mutation in non-small-cell lung cancer patients treated with platinum doublet postoperative chemotherapy.
Cancer Sci
; 113(1): 287-296, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34689382
6.
Performance of Idylla™ RAS-BRAF mutation test for formalin-fixed paraffin-embedded tissues of colorectal cancer.
Int J Clin Oncol
; 27(7): 1180-1187, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35474548
7.
Genetic profile of adult T-cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV-1 strains.
Cancer Sci
; 112(3): 1300-1309, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33426772
8.
Tumor mutation burden as a biomarker for lung cancer patients treated with pemetrexed and cisplatin (the JIPANG-TR).
Cancer Sci
; 112(1): 388-396, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33185928
9.
Nintedanib promotes antitumour immunity and shows antitumour activity in combination with PD-1 blockade in mice: potential role of cancer-associated fibroblasts.
Br J Cancer
; 124(5): 914-924, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33299131
10.
A Novel Malignant Peritoneal Mesothelioma with STRN Exon 2 and ALK Exon 20: A Case Report and Literature Review.
Oncologist
; 26(5): 356-361, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33555117
11.
Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors.
Oncologist
; 26(4): e588-e596, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33325566
12.
Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma.
Mod Pathol
; 34(11): 2071-2079, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34172890
13.
The Japanese Society of Pathology Practical Guidelines on the handling of pathological tissue samples for cancer genomic medicine.
Pathol Int
; 71(11): 725-740, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34614280
14.
CAPP-seq analysis of circulating tumor DNA from patients with EGFR T790M-positive lung cancer after osimertinib.
Int J Clin Oncol
; 26(9): 1628-1639, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34117553
15.
Longitudinal monitoring of somatic genetic alterations in circulating cell-free DNA during treatment with epidermal growth factor receptor-tyrosine kinase inhibitors.
Cancer
; 126(1): 219-227, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31503343
16.
Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M-positive non-small cell lung cancer: West Japan Oncology Group 8815L/LPS study.
Cancer
; 126(9): 1940-1948, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32022929
17.
Intratumor heterogeneity and homologous recombination deficiency of high-grade serous ovarian cancer are associated with prognosis and molecular subtype and change in treatment course.
Gynecol Oncol
; 156(2): 415-422, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31785864
18.
Performance of Oncomine Fusion Transcript kit for formalin-fixed, paraffin-embedded lung cancer specimens.
Cancer Sci
; 110(6): 2044-2049, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30972901
19.
Mutational activation of the epidermal growth factor receptor down-regulates major histocompatibility complex class I expression via the extracellular signal-regulated kinase in non-small cell lung cancer.
Cancer Sci
; 110(1): 52-60, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30390416
20.
Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patients.
Cancer Sci
; 110(10): 3350-3357, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31361375